Condition
Orthostatic Hypertension
Total Trials
4
Recruiting
1
Active
1
Completed
1
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 25/100
Termination Rate
0.0%
0 terminated out of 4 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
100%
1 of 1 completed with results
Key Signals
1 with results100% success
Data Visualizations
Phase Distribution
3Total
Not Applicable (2)
P 1 (1)
Trial Status
Withdrawn1
Recruiting1
Completed1
Unknown1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT07504055Not ApplicableRecruiting
Non-invasive Spinal Cord Stimulation and Blood Pressure Regulation After Spinal Cord Injury
NCT06252376Not ApplicableWithdrawn
Effects of Blood Pressure on Cognition and Cerebral Hemodynamics in PD
NCT02415192Unknown
Observational Study to Evaluate the Safety and Efficacy for Levacalm Tab. Versus Valsartan/Amlodipine Combination Therapy in Essential Hypertension Patients
NCT01285908Phase 1CompletedPrimary
Intravenous Norepinephrine for Orthostatic Hypotension
Showing all 4 trials